Lead Product(s) : Triacetyluridine
Therapeutic Area : Genetic Disease
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria
Details : Uridine Triacetate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hereditary Orotic Aciduria.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 10, 2014
Lead Product(s) : Triacetyluridine
Therapeutic Area : Genetic Disease
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Triacetyluridine
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Uridine Triacetate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Chemotherapy-associated Toxicity.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 12, 2011
Lead Product(s) : Triacetyluridine
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
